APR, 11% Stake Lockup to Expire Next Month
The mandatory lock-up registration on 11% of the shares of APR, a beauty tech company considered the first major KOSPI listing this year, will be lifted next month. If a large volume is released into the market for profit-taking, stock price volatility may increase, so investors should exercise caution.
According to the Korea Securities Depository on the 29th, 11.53% of APR's shares will be released from the lock-up in March. In April, 11.68% of the shares are expected to be released into the market.
Founded in 2014, APR gained popularity with its "Kim Hee-sun beauty device." It is a global beauty tech company building a diverse brand portfolio centered on home beauty devices and cosmetics. Currently, it owns beauty brands such as Mediheal, Aprilskin, Forment, and GlamD Bio, as well as fashion brand NERDY and instant photo booth brand Photogray.
APR, the first KOSPI IPO of the year, closed trading on the 27th at 317,500 KRW, up 67,500 KRW (27%) from the IPO price of 250,000 KRW.
Hot Picks Today
Cracks in Samsung and SK hynix’s Duopoly?... Micron’s Bet with the ‘100,000 HBM Wafers’ Bomb [ChipTalk]
- "Overshooting Oil Prices" Triggers Emergency... Trump Pressures Refiners with 'Wartime Act' Card
- 'Lee Jung-jae as Major Shareholder' Entertainment Agency Wins Second Trial in 4.4 Billion Won Damages Lawsuit
- "This Is the Must-Visit Spot for Foreigners in Korea—Not Olive Young or Daiso... How Foreign Tourists Are Changing the Profit Formula [Weekend Money]"
- "Don't Send Your Kids to School": Jung Hyungdon Explains His Conviction
The shares to be released from mandatory lock-up in March include 2.45 million shares from 5 companies on the KOSPI market and 272.76 million shares from 46 companies on the KOSDAQ market. The top three companies by the number of shares released relative to total issued shares are Yulchon (61.08%), Inwave Systems (60.14%), and Udeumji Pharm (39.89%). The top three companies by the number of shares released are NeoImmunTech KDR (26.43 million shares), HL Biotech Innovation (25.93 million shares), and M-Venture Investment (21 million shares).
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.